Addressing these limitations through more extensive prospective studies with standardized methodologies and comprehensive data collection protocols will be crucial for advancing our understanding of the utility of arachidonic acid, IL-6, and CRP as biomarkers in infectious diseases. This evidence concerns the gene IL6 and infectious disease.